Gene | CSAB (n = 12) | CnSAB (n = 78) | p | Total (N/%) | ||
---|---|---|---|---|---|---|
N | Prevalence rate(%) | N | Prevalence rate (%) | |||
bla SIM | 0 | 0 | 0 | 0 | – | 0 (0.0) |
bla VIM | 0 | 0 | 0 | 0 | – | 0 (0.0) |
bla IMP | 0 | 0 | 0 | 0 | – | 0 (0.0) |
bla NDM−1 | 0 | 0 | 5 | 6.4 | 0.37 | 5 (5.6) |
bla OXA−23−like | 4 | 33.3 | 71 | 91 | < 0.001 | 75 (83.3) |
bla OXA−24/40−like | 0 | 0 | 1 | 1.3 | 0.69 | 1 (1.1) |
bla OXA−51−like | 12 | 100 | 78 | 100 | – | 90 (100) |
bla OXA−58−like | 0 | 0 | 2 | 2.6 | 0.57 | 2 (2.2) |
ISAba1/blaOXA−51−like | 0 | 0 | 22 | 28.2 | 0.034 | 22 (24.4) |
bla OXA−23−like & blaOXA−24/40−like | 0 | 0 | 1 | 1.3 | – | 1 (1.1) |
bla OXA−23−like & blaOXA−58−like | 0 | 0 | 2 | 2.6 | – | 2 (2.2) |
bla OXA−23−like& ISAba1/blaOXA−51−like | 0 | 0 | 22 | 28.2 | 0.034 | 22 (24.4) |